Performance Comparison
Portfolio Performance Comparison
| Name | YTD Return | 1Yr AR | 3Yr AR | 5Yr AR | 10Yr AR | 15Yr AR | 20Yr AR | Common | Inception |
|---|---|---|---|---|---|---|---|---|---|
| ACRX (AcelRx Pharmaceuticals Inc) | NA | 2.73% | -20.16% | -18.22% | -21.12% | NA | NA | … | … |
Data as of 03/12/2024, Common starting date is 02/11/2011
More Performance Analytics Comparison
| Name | Start Date | End Date |
|---|---|---|
| ACRX (AcelRx Pharmaceuticals Inc) | 02/11/2011 | 03/12/2024 |
| Last 1 Week | 1 Yr | 3 Yr | 5 Yr | 10 Yr | 15 Yr | 20 Yr | Common | Inception | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annualized Return (%) | -9.60 | 2.73 | -20.16 | -18.22 | -21.12 | NA | NA | … | … | 52.70 | -67.70 | 303.57 | -54.84 | -41.23 | -8.66 | 13.79 | -21.92 | -32.47 | -42.79 | -40.50 | 165.49 | 121.87 | -57.80 |
| Sharpe Ratio | NA | -0.07 | -0.11 | -0.12 | -0.17 | NA | NA | … | … | 5.91 | -0.74 | 0.96 | -0.58 | -0.42 | -0.50 | -0.10 | -0.36 | -1.08 | -0.70 | -0.71 | 2.16 | 1.44 | -1.35 |
| Standard Deviation(%) | NA | 110.10 | 197.82 | 164.07 | 131.56 | NA | NA | … | … | 131.64 | 97.66 | 317.18 | 94.54 | 99.06 | 63.37 | 79.98 | 116.28 | 61.59 | 87.77 | 83.09 | 68.12 | 72.48 | 61.58 |
| Draw Down(%) | NA | 65.41 | 91.89 | 95.42 | 98.62 | NA | NA | … | … | 28.33 | 82.24 | 70.49 | 82.31 | 63.98 | 57.76 | 55.62 | 68.18 | 42.46 | 67.14 | 59.09 | 49.31 | 33.40 | 60.00 |
| Yield(%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | … | … | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Data as of 03/12/2024, Common starting date is 02/11/2011
Performance Comparison Chart
Annualized Rolling Returns Comparison (Minimum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| ACRX (AcelRx Pharmaceuticals Inc) |
-59.88%
Apr 2019 – Apr 2022 |
-46.06%
Sep 2017 – Sep 2022 |
-25.34%
Sep 2013 – Sep 2023 |
0.00%
NA |
Annualized Rolling Returns Comparison (Maximum)
| Ticker/Portfolio Name | 3 Year | 5 Year | 10 Year | 15 Year |
|---|---|---|---|---|
| ACRX (AcelRx Pharmaceuticals Inc) |
51.90%
Dec 2011 – Dec 2014 |
7.60%
Sep 2012 – Sep 2017 |
-1.27%
Oct 2012 – Oct 2022 |
0.00%
NA |
Annualized Rolling Returns Comparison Chart